Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Apollo Endosurgery Inc (APEN)

Apollo Endosurgery Inc (APEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apollo Endosurgery Inc 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746 USA

www.apolloendo.com P: 512-279-5100 F: 512-279-5105

Description:

Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.

Key Statistics

Overview:

Market Capitalization, $K 579,720
Enterprise Value, $K 576,390
Shares Outstanding, K 57,972
Annual Sales, $ 76,860 K
Annual Net Income, $ -39,840 K
Last Quarter Sales, $ 21,310 K
Last Quarter Net Income, $ -9,550 K
60-Month Beta 2.31
% of Insider Shareholders 17.30%
% of Institutional Shareholders 76.01%
Float, K 47,943
% Float 82.70%
Short Volume Ratio 0.19

Growth:

1-Year Return 67.22%
3-Year Return 360.83%
5-Year Return 69.49%
5-Year Revenue Growth 19.51%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 11/01/22
Next Earnings Date 05/02/23
Earnings Per Share ttm -0.75
EPS Growth vs. Prev Qtr -7.69%
EPS Growth vs. Prev Year -21.74%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-11 on 12/30/16

APEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -89.48%
Return-on-Assets % -33.76%
Profit Margin % -51.83%
Debt/Equity 1.04
Price/Sales 7.48
Price/Cash Flow N/A
Price/Book 14.59
Book Value/Share 0.69
Interest Coverage -7.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar